12 Nov 2021
11:45 E.S.T.

Mesothelin (MSLN) Targeting Allogeneic CAR T Cells Engineedred to Overcome Tumor Immunosuppressive Microenvironment- SITC 2021

Download the PDF file

27 Oct 2021
09:18 E.S.T.

Preclinical development of a TALEN-based genome editing in T cells for the treatment of Hyper-IgE-Syndrome - ESGCT 2021

Download the PDF file

27 Oct 2021
09:15 E.S.T.

Preclinical development of a TALEN-based genome editing therapy for RAG1 deficiency - ESGCT 2021

Download the PDF file